Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 2—February 2017

Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris

Leighann Sherry, Gordon Ramage, Ryan Kean, Andrew Borman, Elizabeth M. Johnson, Malcolm D. Richardson, and Riina Rautemaa-RichardsonComments to Author 
Author affiliations: University of Glasgow, Glasgow, Scotland, UK (L. Sherry, G. Ramage, R. Kean); Public Health England, Bristol, UK (A. Borman, E.M. Johnson); The University of Manchester, Manchester, UK (M.D. Richardson, R. Rautemaa-Richardson); University Hospital of South Manchester, Manchester (M.D. Richardson, R. Rautemaa-Richardson)

Main Article

Table 1

Planktonic susceptibility profiles of 7 antifungals against Candida auris yeast

Planktonic MIC*
Strain 2
Strain 6
Strain 10
Strain 12
Fluconazole >32 >32 >32 >32
Voriconazole 8 8 32 1
Caspofungin 32 32 2 >32
Micafungin 0.5 <0.0625 <0.06 <0.0625
Liposomal amphotericin B 0.25 0.25 0.5 1
Amphotericin B 0.25 0.25 0.5 0.5
Chlorhexidine, % <0.02 <0.02 <0.02 <0.02

*Values are mg/L except as indicated. All MIC tests were performed on 3 independent occasions, showing identical results each time.

Main Article

Page created: January 17, 2017
Page updated: January 17, 2017
Page reviewed: January 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.